Miyako Kishimoto

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes

Miyako Kishimoto · Diabetes Metabolic Syndrome and Obesity · 2013 · 124 citations · Full text

Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease During Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients

Tetsuro Tsujimoto, Ritsuko Yamamoto‐Honda, Hiroshi Kajio et al. · Diabetes Care · 2013 · 96 citations · Full text

Metabolic Syndrome, Hypertension, Severe Hypoglycemia +14

Behavioral changes in patients with diabetes during the COVID-19 pandemic

Miyako Kishimoto, Takuya Ishikawa, Masato Odawara · Diabetology International · 2020 · 53 citations · Full text

Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease

Tetsuro Tsujimoto, Ritsuko Yamamoto‐Honda, Hiroshi Kajio et al. · Acta Diabetologica · 2014 · 45 citations · Full text

Body Mass Index, Fasting Plasma Glucose Levels, and C-peptide Levels as Predictors of the Future Insulin Use in Japanese Type 2 Diabetic Patients

Atsushi Goto, Maki Takaichi, Miyako Kishimoto et al. · Endocrine Journal · 2010 · 41 citations · Full text

Nutrition, Japanese Type 2, Future Insulin Use +18